Validation of the European Organization for Research and Treatment of Cancer QLQ-LMC21 questionnaire for assessment of patient-reported outcomes during treatment of colorectal liver metastases

British Journal of Surgery

Volumn 96, Issue 3, 2009, Pages 291-298

  Blazeby, J M ^a,b   Fayers, P ^c,e   Conroy, T ^f   Sezer, O ^g   Ramage, J ^d   Rees, M ^d  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^f CENTRE ALEXIS VAUTRIN   (France)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CRITERION RELATED VALIDITY; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; STRUCTURED QUESTIONNAIRE; TREATMENT OUTCOME; VALIDATION STUDY; CLINICAL TRIAL; COLORECTAL TUMOR; LIVER TUMOR; METASTASIS; MIDDLE AGED; MULTICENTER STUDY; PALLIATIVE THERAPY; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REPRODUCIBILITY;

COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PALLIATIVE CARE; PATIENT COMPLIANCE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 61749089135     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6471     Document Type: Article

References (17)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 18-29.
2. Sprangers MAG, Cull A, Groenvold M, Bjordal K, Blazeby JM, Aaronson NK et al. The European Organization for Research and Treatment of Cancer approach to developing questionnaire modules: an update and overview. EORTC Quality of Life Study Group. Qual Life Res 1998; 7: 291-300.
3. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
4. Kavadas V, Blazeby JM, Conroy T, Sezer O, Holzner B, Roller M et al. Development of an EORTC disease-specific quality of life questionnaire for use in patients with liver metastases from colorectal cancer. Eur J Cancer 2003; 39: 1259-1263.
5. Roller M, Aaronson NK, Blazeby J, Bottomley A, Dewolf L, Fayers P et al. Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach. Eur J Cancer 2007; 43: 1810-1820.
6. Nunnally JC. Psychometric Theory (2nd edn). McGraw-Hill: New York, 1978.
7. Fayers PM, Machin D. Quality of Life: Assessment, Analysis and Interpretation. John Wiley: Chichester, 2000.
8. Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, on behalf of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Study Group. The EORTC QLQ-C30 Scoring Manual (3rd edn). EORTC: Brussels, 2001.
9. EORTC group for research into quality of life. Quality of Life. http://groups.eortc.be/qo [accessed 4 Nov 2008].
10. Dasgupta D, Smith AB, Hamilton-Burke W, Prasad RR, Toogood GJ, Velikova G et al. Quality of life after liver resection for hepatobiliary malignancies. Br J Surg 2008; 95: 845-854.
11. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A et al. The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570-579.
12. Heffernan N, Cella D, Webster K, Odom L, Martone M, Passik S et al. Measuring health-related quality of life in patients with hepatobiliary cancers: the functional assessment of cancer therapy - hepatobiliary questionnaire. J Clin Oncol 2002; 20: 2229-2239.
13. Blazeby JM, Currie E, Zee BC, Chie WC, Poon RT, Garden OJ. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18. Eur J Cancer 2004; 40: 2439-2444.
14. Fitzsimmons D, Johnson CD, George S, Payne S, Sandberg AA, Bassi C et al. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer 1999; 35: 939-941.
15. Gujral S, Conroy T, Fleissner C, Sezer O, King PM, Avery RN et al. Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire. EurJ Cancer 2007; 43: 1564-1573.
16. Blazeby JM, Avery K, Sprangers M, Pikhart H, Fayers P, Donovan J. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol 2006; 24: 3178-3186.
17. Brundage M, Feldman-Stewart D, Leis A, Bezjak A, Degner L, Velji K et al. Communicating quality of life information to cancer patients: a study of six presentation formats. J Clin Oncol 2005; 23: 6949-6956.